The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.
The affidavit is the government's third submission to the SC in response to a writ petition filed by social worker Harisharan Devgan & others challenging the January cut-off revision.
Nordisk’s India managing director told ThePrint, his company has now moved to higher-dose Semaglutide, oral formulations and two new therapies which are advancing as cardiometabolic care.
Warning-style labels are 'overly simplistic' & could mislead or alarm consumers, say industry voices. Consumer groups say industry views dominated talks, and a basic health measure meant to inform the public is being avoided.
New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than previously thought, often between the ages of 45 and 65.
Guidelines by American College of Cardiology, American Heart Association & other organisations endorse early detection and treatment of dyslipidemia—unhealthy levels of fats in blood.
States have consistently underspent funds under District Mental Health Programme, which involves OPD, community outreach, awareness & training of healthcare workers in districts.
Kerala researchers study 386 products, covering Ayurveda, Homoeopathy, Siddha, Unani, other traditional remedies. Findings raise concerns about regulatory oversight of Ayush meds.
Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.
Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, this strength in finished formulations relies on imported ingredients.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS